MedMen Stock Hits New Low: Is the End in Sight?
MedMen stock has sunk to a new low of just $0.18 today, just weeks after the departure of controversial CEO Adam Bierman and the release of dismal Q2 earnings. This disastrous performance has many investors ... [Read]
Organigram Stock Hits New Low: Where Will It Go from Here?
Organigram stock continues to new lows on broader market weakness and severe correction in the cannabis sector. Let's analyze whether or not Organigram Holdings (TSX:OGI) (NASDAQ:OGI) is positioned to rebound. The global economic climate is ... [Read]
Organigram Stock Gains on New Leadership Appointments
Organigram stock is making gains today after Organigram Holdings (TSX:OGI) (NASDAQ:OGI) announced two new appointments to the positions of Chief Strategy Officer and Chief Financial Officer. The Moncton-based pot producer said in a March 4 ... [Read]
MedMen Stock Continues to Fall After Poor Earnings Performance
MedMen Enterprises (CSE:MMEN) (OTCQX:MMNFF) has been in trouble for quite some time, and the disappointment with the company’s recent fiscal second-quarter financial results has resulted in another selloff in MedMen stock. Disappointing Earnings MedMen is ... [Read]
Organigram Stock Makes a Solid Case for Big Gains in 2.0 Market
Organigram stock is making gains on Monday as the Canadian cannabis producer looks to the legalization 2.0 market to help transform its fortunes after a disappointing year in 2019. After a difficult first year of ... [Read]
Organigram Stock Flat Despite Role in Legionnaires’ Outbreak
Organigram stock is unmoved today despite new documents highlighting discussions between the New Brunswick health department and Organigram Holdings (TSX:OGI) (NASDAQ:OGI) as the province investigated an outbreak of Legionnaires' disease in Moncton last year that ... [Read]
MedMen Stock Continues to Slide Ahead of Earnings
MedMen stock is continuing to trade in the red today as the troubled pot firm prepares to release its second-quarter earnings later this week. US pot retailer MedMen Enterprises (CSE:MMEN) (OTCQX:MMNFF) has been in hot ... [Read]
Organigram Stock Down Despite Further Cannabis 2.0 Releases
Organigram stock is in the red on Monday despite Organigram Holdings (TSX:OGI) (NASDAQ:OGI) announcing the release of new cannabis derivative products, including vape pens and cannabis-infused chocolate. Organigram Stock Down Despite Vape Shipment Organigram Holdings ... [Read]
MedMen Stock Drops After Settling $3.3 Million Debt with Share Issuance
MedMen stock is continuing to slide today after it was reported that MedMen Enterprises (CSE:MMEN) (OTCQX:MMNFF) had squared up C$3.3 million in vendor debt with the issuance of Class B subordinate voting shares. The California-based ... [Read]
Namaste Stock Consolidates After Gaining Momentum in January
Cannabis e-commerce company Namaste Technologies (TSXV:N) (OTCQB:NXTTF) has managed to engineer a remarkable rebound over the past months. In that time, Namaste stock has managed to generate gains of 50%, and in such a situation, ... [Read]